Previous Article | Next Article 
Molecular and Cellular Biology, April 2002, p. 2716-2727, Vol. 22, No. 8
0270-7306/02/$04.00+0 DOI: 10.1128/MCB.22.8.2716-2727.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Activation of m-Calpain (Calpain II) by Epidermal Growth Factor Is Limited by Protein Kinase A Phosphorylation of m-Calpain
Hidenori Shiraha,1 Angela Glading,1 Jeffrey Chou,1 Zongchao Jia,2 and Alan Wells1*
Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania 15261,1
Department of Biochemistry, Queen's University, Kingston, Ontario, Canada K7L 3N62
Received 10 July 2001/
Returned for modification 20 August 2001/
Accepted 4 January 2002
We have shown previously that the ELR-negative CXC chemokines interferon-inducible protein 10, monokine induced by gamma interferon, and platelet factor 4 inhibit epidermal growth factor (EGF)-induced m-calpain activation and thereby EGF-induced fibroblast cell motility (H. Shiraha, A. Glading, K. Gupta, and A. Wells, J. Cell Biol. 146:243-253, 1999). However, how this cross attenuation could be accomplished remained unknown since the molecular basis of physiological m-calpain regulation is unknown. As the initial operative attenuation signal from the CXCR3 receptor was cyclic AMP (cAMP), we verified that this second messenger blocked EGF-induced motility of fibroblasts (55% ± 4.5% inhibition) by preventing rear release during active locomotion. EGF-induced calpain activation was inhibited by cAMP activation of protein kinase A (PKA), as the PKA inhibitors H-89 and Rp-8Br-cAMPS abrogated cAMP inhibition of both motility and calpain activation. We hypothesized that PKA might negatively modulate m-calpain in an unexpected manner by directly phosphorylating m-calpain. A mutant human large subunit of m-calpain was genetically engineered to negate a putative PKA consensus sequence in the regulatory domain III (ST369/370AA) and was expressed in NR6WT mouse fibroblasts to represent about 30% of total m-calpain in these cells. This construct was not phosphorylated by PKA in vitro while a wild-type construct was, providing proof of the principle that m-calpain can be directly phosphorylated by PKA at this site. cAMP suppressed EGF-induced calpain activity of cells overexpressing a control wild-type human m-calpain (83% ± 3.7% inhibition) but only marginally suppressed that of cells expressing the PKA-resistant mutant human m-calpain (25% ± 5.5% inhibition). The EGF-induced motility of the cells expressing the PKA-resistant mutant also was not inhibited by cAMP. Structural modeling revealed that new constraints resulting from phosphorylation at serine 369 would restrict domain movement and help "freeze" m-calpain in an inactive state. These data point to a novel mechanism of negative control of calpain activation, direct phosphorylation by PKA.
* Corresponding author. Mailing address: Department of Pathology, University of Pittsburgh, S713 Scaife, Terrace and Lothrop Street, Pittsburgh, PA 15261. Phone: (412) 624-0973. Fax: (412) 647-8567. E-mail:
wells{at}msx.upmc.edu.
Molecular and Cellular Biology, April 2002, p. 2716-2727, Vol. 22, No. 8
0022-538X/02/$04.00+0 DOI: 10.1128/MCB.22.8.2716-2727.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Li, Y., Li, Y., Feng, Q., Arnold, M., Peng, T.
(2009). Calpain activation contributes to hyperglycaemia-induced apoptosis in cardiomyocytes. Cardiovasc Res
84: 100-110
[Abstract]
[Full Text]
-
Bodnar, R. J., Yates, C. C., Rodgers, M. E., Du, X., Wells, A.
(2009). IP-10 induces dissociation of newly formed blood vessels. J. Cell Sci.
122: 2064-2077
[Abstract]
[Full Text]
-
Okamura, D. M., Pennathur, S., Pasichnyk, K., Lopez-Guisa, J. M., Collins, S., Febbraio, M., Heinecke, J., Eddy, A. A.
(2009). CD36 Regulates Oxidative Stress and Inflammation in Hypercholesterolemic CKD. J. Am. Soc. Nephrol.
20: 495-505
[Abstract]
[Full Text]
-
Yates, C. C., Whaley, D., Y-Chen, A., Kulesekaran, P., Hebda, P. A., Wells, A.
(2008). ELR-Negative CXC Chemokine CXCL11 (IP-9/I-TAC) Facilitates Dermal and Epidermal Maturation during Wound Repair. Am. J. Pathol.
173: 643-652
[Abstract]
[Full Text]
-
Yates, C. C., Whaley, D., Kulasekeran, P., Hancock, W. W., Lu, B., Bodnar, R., Newsome, J., Hebda, P. A., Wells, A.
(2007). Delayed and Deficient Dermal Maturation in Mice Lacking the CXCR3 ELR-Negative CXC Chemokine Receptor. Am. J. Pathol.
171: 484-495
[Abstract]
[Full Text]
-
Nuzzi, P. A., Senetar, M. A., Huttenlocher, A.
(2007). Asymmetric Localization of Calpain 2 during Neutrophil Chemotaxis. Mol. Biol. Cell
18: 795-805
[Abstract]
[Full Text]
-
Shao, H., Chou, J., Baty, C. J., Burke, N. A., Watkins, S. C., Stolz, D. B., Wells, A.
(2006). Spatial Localization of m-Calpain to the Plasma Membrane by Phosphoinositide Biphosphate Binding during Epidermal Growth Factor Receptor-Mediated Activation.. Mol. Cell. Biol.
26: 5481-5496
[Abstract]
[Full Text]
-
Su, Y., Cui, Z., Li, Z., Block, E. R.
(2006). Calpain-2 regulation of VEGF-mediated angiogenesis. FASEB J.
20: 1443-1451
[Abstract]
[Full Text]
-
Marzia, M., Chiusaroli, R., Neff, L., Kim, N.-Y., Chishti, A. H., Baron, R., Horne, W. C.
(2006). Calpain Is Required for Normal Osteoclast Function and Is Down-regulated by Calcitonin. J. Biol. Chem.
281: 9745-9754
[Abstract]
[Full Text]
-
Bodnar, R. J., Yates, C. C., Wells, A.
(2006). IP-10 Blocks Vascular Endothelial Growth Factor-Induced Endothelial Cell Motility and Tube Formation via Inhibition of Calpain. Circ. Res.
98: 617-625
[Abstract]
[Full Text]
-
Xu, L., Deng, X.
(2006). Protein Kinase C{iota} Promotes Nicotine-induced Migration and Invasion of Cancer Cells via Phosphorylation of {micro}- and m-Calpains. J. Biol. Chem.
281: 4457-4466
[Abstract]
[Full Text]
-
Howe, A. K., Baldor, L. C., Hogan, B. P.
(2005). Spatial regulation of the cAMP-dependent protein kinase during chemotactic cell migration. Proc. Natl. Acad. Sci. USA
102: 14320-14325
[Abstract]
[Full Text]
-
Franco, S. J., Huttenlocher, A.
(2005). Regulating cell migration: calpains make the cut. J. Cell Sci.
118: 3829-3838
[Abstract]
[Full Text]
-
Satish, L., Blair, H. C., Glading, A., Wells, A.
(2005). Interferon-Inducible Protein 9 (CXCL11)-Induced Cell Motility in Keratinocytes Requires Calcium Flux-Dependent Activation of {micro}-Calpain. Mol. Cell. Biol.
25: 1922-1941
[Abstract]
[Full Text]
-
Sato, K., Hattori, S., Irie, S., Sorimachi, H., Inomata, M., Kawashima, S.
(2004). Degradation of Fodrin by m-Calpain in Fibroblasts Adhering to Fibrillar Collagen I Gel. J Biochem
136: 777-785
[Abstract]
[Full Text]
-
Inserte, J., Garcia-Dorado, D., Ruiz-Meana, M., Agullo, L., Pina, P., Soler-Soler, J.
(2004). Ischemic preconditioning attenuates calpain-mediated degradation of structural proteins through a protein kinase A-dependent mechanism. Cardiovasc Res
64: 105-114
[Abstract]
[Full Text]
-
Iwabu, A., Smith, K., Allen, F. D., Lauffenburger, D. A., Wells, A.
(2004). Epidermal Growth Factor Induces Fibroblast Contractility and Motility via a Protein Kinase C {delta}-dependent Pathway. J. Biol. Chem.
279: 14551-14560
[Abstract]
[Full Text]
-
Glading, A., Bodnar, R. J., Reynolds, I. J., Shiraha, H., Satish, L., Potter, D. A., Blair, H. C., Wells, A.
(2004). Epidermal Growth Factor Activates m-Calpain (Calpain II), at Least in Part, by Extracellular Signal-Regulated Kinase-Mediated Phosphorylation. Mol. Cell. Biol.
24: 2499-2512
[Abstract]
[Full Text]
-
Suzuki, K., Hata, S., Kawabata, Y., Sorimachi, H.
(2004). Structure, Activation, and Biology of Calpain. Diabetes
53: S12-18
[Abstract]
[Full Text]
-
Mamoune, A., Luo, J.-H., Lauffenburger, D. A., Wells, A.
(2003). Calpain-2 as a Target for Limiting Prostate Cancer Invasion. Cancer Res.
63: 4632-4640
[Abstract]
[Full Text]
-
Wong, J. K., Le, H. H., Zsarnovszky, A., Belcher, S. M.
(2003). Estrogens and ICI182,780 (Faslodex) Modulate Mitosis and Cell Death in Immature Cerebellar Neurons via Rapid Activation of p44/p42 Mitogen-Activated Protein Kinase. J. Neurosci.
23: 4984-4995
[Abstract]
[Full Text]
-
Crocker, S. J., Smith, P. D., Jackson-Lewis, V., Lamba, W. R., Hayley, S. P., Grimm, E., Callaghan, S. M., Slack, R. S., Melloni, E., Przedborski, S., Robertson, G. S., Anisman, H., Merali, Z., Park, D. S.
(2003). Inhibition of Calpains Prevents Neuronal and Behavioral Deficits in an MPTP Mouse Model of Parkinson's Disease. J. Neurosci.
23: 4081-4091
[Abstract]
[Full Text]
-
Gil-Parrado, S., Popp, O., Knoch, T. A., Zahler, S., Bestvater, F., Felgentrager, M., Holloschi, A., Fernandez-Montalvan, A., Auerswald, E. A., Fritz, H., Fuentes-Prior, P., Machleidt, W., Spiess, E.
(2003). Subcellular Localization and in Vivo Subunit Interactions of Ubiquitous {micro}-Calpain. J. Biol. Chem.
278: 16336-16346
[Abstract]
[Full Text]
-
Seck, T., Baron, R., Horne, W. C.
(2003). Binding of Filamin to the C-terminal Tail of the Calcitonin Receptor Controls Recycling. J. Biol. Chem.
278: 10408-10416
[Abstract]
[Full Text]
-
Becraft, P. W., Li, K., Dey, N., Asuncion-Crabb, Y.
(2003). The maize dek1 gene functions in embryonic pattern formation and cell fate specification. Development
129: 5217-5225
[Abstract]
[Full Text]